CAT
Caterpillar Inc.
CAT's fundamentals are strong, but it looks expensive: trading at 24x earnings, above its usual 18x. Analysts expect strong earnings growth, though they disagree widely on how much.
IVDA
Iveda Solutions, Inc.
There isn't enough reported data to score IVDA yet.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
IVDA Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Unavailable | |
| Unavailable |
IVDA's revenue and profitability are currently under pressure. There isn't enough data to rate its cash flow and balance sheet.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT's PE is in its expensive range at 24x. If earnings grow as analysts expect, today's price would be 20x next year's earnings, in its fair range.
IVDA PE Valuation
IVDA has no meaningful PE right now: it lost money over the past year.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for CAT, with profitability improving. However, they disagree widely on these estimates.
IVDA Forward outlook
There aren't enough analyst estimates for IVDA to show an outlook.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $30.32 | +19% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT has the edge over IVDA on earnings quality, reporting a profit while its opponent remains loss making.
IVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.53 | +$0.88 |
| Q1 2026 | -$0.66 | +$0.79 |
| Q4 2025 | -$0.88 | +$0.85 |
| Q3 2025 | -$1.22 | +$0.32 |
| Q2 2025 | -$1.41 | +$0.27 |
| Q1 2025 | -$1.45 | +$0.39 |
| Q4 2024 | -$1.73 | -$0.13 |
| Q3 2024 | -$1.54 | +$0.06 |
IVDA is still losing money, but far less than before: $0.53 per share over the past year, against $8.32 at its worst in early 2016.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT has the edge over IVDA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT has the edge over IVDA on profitability, with a higher operating margin.
IVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $801.8K | -48% |
| Q1 2026 | $1.5M | +1.3% |
| Q4 2025 | $626K | -64% |
| Q3 2025 | $1.7M | -31% |
| Q2 2025 | $1.5M | -0.4% |
| Q1 2025 | $1.5M | +325% |
| Q4 2024 | $1.7M | +70% |
| Q3 2024 | $2.4M | +175% |
IVDA's revenue has slid since its 2024 peak: $801,846 last quarter, down 48% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -89% | -54 points |
| Q1 2026 | -38% | +19 points |
| Q4 2025 | -263% | -160 points |
| Q3 2025 | -13% | +12 points |
| Q2 2025 | -35% | -1.3 points |
| Q1 2025 | -57% | +278 points |
| Q4 2024 | -103% | +7.4 points |
| Q3 2024 | -25% | +79 points |
IVDA's operating margin was −89% last quarter, down 54 points from the same quarter a year ago.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT has the stronger cash trend. Its trailing FCF is up 39% versus its history, compared with IVDA at up 14%.
IVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q1 2026 | -$927.1K | -$801.2K |
| Q3 2025 | -$317K | +$582.7K |
| Q2 2025 | -$1.3M | -$325.9K |
| Q1 2025 | -$126K | +$1.2M |
| Q4 2024 | -$1.2M | -$236.5K |
| Q3 2024 | -$899.7K | +$2M |
| Q2 2024 | -$1M | -342% |
| Q1 2024 | -$1.3M | -$1.3M |
IVDA has burned cash in almost every quarter: −$3M over the past year, against −$4M the year before.
CAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -1.6M shares |
| 1 year | -2.1% | -9.9M shares |
| 3 years | -10% | -51.7M shares |
| 5 years | -16% | -86.7M shares |
| Available history | -19% | -107M shares |
CAT has the edge over IVDA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2B |
| Q2 2026 | $1.5B |
| Q1 2026 | $5B |
| Q4 2025 | $340M |
| Q3 2025 | $362M |
| Q2 2025 | $828M |
| Q1 2025 | $3.7B |
| Q4 2024 | $640M |
CAT spent $8.1B buying back its own shares over the past year, up 47% from the year before.
IVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +32% | +2.9M shares |
| 1 year | +317% | +9M shares |
| 3 years | +519% | +9.9M shares |
| 5 years | +1212% | +10.9M shares |
| Available history | +2594% | +11.4M shares |
IVDA has 12M diluted shares, up 317% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has more cash than debt.
IVDA Net Leverage
IVDA's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
IVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.2 | Neutral |
| Stochastic | 4.0 | Oversold |
IVDA's weekly RSI is 37 (neutral) and its Stochastic is 4 (oversold).
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.3% below |
| PE % | 69 | 58 | 11 pts above |
CAT is trading at 24x earnings, in line with the Industrials sector's median of 24x.
IVDA PE vs Industrials Sector
IVDA has no meaningful PE right now: it lost money over the past year.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has the edge over IVDA on trend strength, trading above more of its moving averages.
IVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.24 | 17% below |
| 20 week MA | $0.28 | 29% below |
| 50 week MA | $0.42 | 52% below |
| 100 week MA | $1.35 | 85% below |
| 200 week MA | $3.78 | 95% below |
IVDA is in a downtrend: it's below all five of its weekly moving averages, and 95% below its 200-week average.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has the edge over IVDA on returns for 2026, with the stronger performance.
IVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $21.8 | $32.0 | +47% |
| 2021 | $32.0 | $128.6 | +302% |
| 2022 | $128.6 | $4.64 | -96% |
| 2023 | $4.64 | $5.07 | +9.3% |
| 2024 | $5.07 | $5.53 | +9.1% |
| 2025 | $5.53 | $0.89 | -84% |
| 2026 YTD | $0.89 | $0.20 | -78% |
IVDA's yearly returns have swung widely, from +302% in 2021 to −96% in 2022. It's down 78% so far in 2026.